Clinical Trial Update: Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II study evaluating radiation therapy with vismodegib for locally advanced basal cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Malignancy
• Skin Cancer

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: Sue Yom | Conditions: Locally Advanced Basal Cell Carcinoma, Skin Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-10-05